<DOC>
	<DOCNO>NCT02185092</DOCNO>
	<brief_summary>The purpose study examine hypothesis test probiotic reduce frequency exacerbation patient COPD .</brief_summary>
	<brief_title>Probiotic Use Patients With Prior COPD Exacerbation</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<criteria>1 . Patients admit OUMC VAMC COPD exacerbation pneumonia underlie COPD eligible screen . 2 . Patients see VA Chest Medicine clinic , OU Physicians clinic Pulmonary fellows clinic PPOB COPD exacerbation within last year . 3 . Patients age 18 4 . Patients pulmonary function test ( PFT ) show COPD within 1 year enrollment study treat physician plan obtain PFT part patient 's care plan . 5 . Patients consider diagnosis COPD FEV1 le 80 % predict FVC/FEV1 ratio le 0.70 ( define GOLD criterion ) . 1 . Patients less one year life expectancy concomitant diagnosis 2 . Any GI motility disorder previous bowel resection surgery ( short gut syndrome ) 3 . Any patient decrease immune function medication may decrease immune function ( low dose steroid steroid taper ) . 4 . Patients admit within last one year diagnosis pancreatitis 5 . Patients unable give consent include study . 6 . Patients unable sign consent 7 . Patients already azithromycin daily COPD exacerbation 8 . Patients department correction custody .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>exacerbation</keyword>
	<keyword>COPD</keyword>
	<keyword>pneumonia</keyword>
	<keyword>probiotic</keyword>
</DOC>